Chronic Prostatitis Collaborative Research Network (Cpcrn)
The summary for the Chronic Prostatitis Collaborative Research Network (Cpcrn) Federal Grant is detailed below.
It contains information such as the Catalog of Federal Domestic Assistance (CFDA) number, who is eligible for the grant, how much grant money will be awarded, important deadlines, and a sampling of similar government grants.
Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed in the Grant Announcement Contact section.
If these sections are incomplete, please visit the website of the government agency that is offering this grant.
Federal Grant Title:
CHRONIC PROSTATITIS COLLABORATIVE RESEARCH NETWORK (CPCRN)
State governments County governments City or township governments Special district governments Independent school districts Public and State controlled institutions of higher education Native American tribal governments (Federally recognized) Public housing authorities/Indian housing authorities Native American tribal organizations (other than Federally recognized tribal governments) Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Private institutions of higher education Individuals For profit organizations other than small businesses Small businesses Others (see text field entitled "Additional Information on Eligibility" for clarification)
Additional Information on Eligibility
Information not provided
The Division of Kidney, Urologic and Hematologic Diseases (DKUHD) of the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) invites cooperative agreement applications for up to 10 Clinical Centers to participate in the development and conduct of randomized clinical trials to evaluate novel therapies in patients with chronic prostatitis/Chronic Pelvic Pain Syndrome as part of the Chronic Prostatitis Collaborative Research Network (CPCRN). A Data Coordinating Center will be established to provide expertise in protocol development including sample size estimation, data analysis, quality control, and data management. The Data Coordinating Center will be established through a separate cooperative agreement Request for Applications. Ancillary studies will also be developed by the CPCRN investigators to be conducted in conjunction with the clinical trials. The Clinical Centers and the Data Coordinating Center will work cooperatively to conduct clinical trials sequentially or concurrently. Because there is substantial commonality in the design and conduct of clinical trials for patients with chronic prostatitis, or the chronic pelvic pain syndrome, and interstitial cystitis applicants to this RFA are invited, but not required to apply to a companion RFA also being released. The companion RFA, DK-03-003, titled, Interstitial Cystitis Clinical Research Network (ICCRN) is available at: http://grants.nih.gov/grants/guide/rfa-files/RFA-DK-03-003.html. Investigators from the CPCRN and the ICCRN will participate in an overarching organization, the Urological Chronic Pelvic Pain Syndromes Collaborative Group (UCPPSCG). The UCPPSCG will serve to improve the efficiency of protocol development, to develop common definitions and criteria, and to facilitate common data collection to permit comparisons between the clinical trials. This coordination is needed in key areas of protocol development including establishment of disease and enrollment criteria, outcome measures, and identification of therapies to be evaluated.